A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Clinical trial NCT06969430 · RECRUITING
Trial details
- NCT number
- NCT06969430
- Sponsor
- Debiopharm International SA
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-30
- Primary completion
- 2031-11-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.